Global and United States Human Chorionic Gonadotropin (HCG) Market Report & Forecast 2023-2028

Report ID: 1842470 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Chorionic Gonadotropin (HCG) Product Introduction
    1.2 Global Human Chorionic Gonadotropin (HCG) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Human Chorionic Gonadotropin (HCG) Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Human Chorionic Gonadotropin (HCG) Sales in Volume for the Year 2017-2028
    1.3 United States Human Chorionic Gonadotropin (HCG) Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Human Chorionic Gonadotropin (HCG) Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Human Chorionic Gonadotropin (HCG) Sales in Volume for the Year 2017-2028
    1.4 Human Chorionic Gonadotropin (HCG) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Human Chorionic Gonadotropin (HCG) in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Human Chorionic Gonadotropin (HCG) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Human Chorionic Gonadotropin (HCG) Market Dynamics
        1.5.1 Human Chorionic Gonadotropin (HCG) Industry Trends
        1.5.2 Human Chorionic Gonadotropin (HCG) Market Drivers
        1.5.3 Human Chorionic Gonadotropin (HCG) Market Challenges
        1.5.4 Human Chorionic Gonadotropin (HCG) Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Human Chorionic Gonadotropin (HCG) Market Segment by Type
        2.1.1 Natural Source Extraction
        2.1.2 Recombinant DNA Technology
    2.2 Global Human Chorionic Gonadotropin (HCG) Market Size by Type
        2.2.1 Global Human Chorionic Gonadotropin (HCG) Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Human Chorionic Gonadotropin (HCG) Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Human Chorionic Gonadotropin (HCG) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Human Chorionic Gonadotropin (HCG) Market Size by Type
        2.3.1 United States Human Chorionic Gonadotropin (HCG) Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Human Chorionic Gonadotropin (HCG) Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Human Chorionic Gonadotropin (HCG) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Human Chorionic Gonadotropin (HCG) Market Segment by Application
        3.1.1 Female Infertility Treatment
        3.1.2 Oligospermic Treatment
        3.1.3 Cryptorchidism Treatment
        3.1.4 Others
    3.2 Global Human Chorionic Gonadotropin (HCG) Market Size by Application
        3.2.1 Global Human Chorionic Gonadotropin (HCG) Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Human Chorionic Gonadotropin (HCG) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Human Chorionic Gonadotropin (HCG) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Human Chorionic Gonadotropin (HCG) Market Size by Application
        3.3.1 United States Human Chorionic Gonadotropin (HCG) Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Human Chorionic Gonadotropin (HCG) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Human Chorionic Gonadotropin (HCG) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Human Chorionic Gonadotropin (HCG) Competitor Landscape by Company
    4.1 Global Human Chorionic Gonadotropin (HCG) Market Size by Company
        4.1.1 Top Global Human Chorionic Gonadotropin (HCG) Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturer (2017-2022)
        4.1.3 Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturer (2017-2022)
        4.1.4 Global Human Chorionic Gonadotropin (HCG) Price by Manufacturer (2017-2022)
    4.2 Global Human Chorionic Gonadotropin (HCG) Concentration Ratio (CR)
        4.2.1 Human Chorionic Gonadotropin (HCG) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Chorionic Gonadotropin (HCG) in 2021
        4.2.3 Global Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Human Chorionic Gonadotropin (HCG) Manufacturing Base Distribution, Product Type
        4.3.1 Global Human Chorionic Gonadotropin (HCG) Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
        4.3.3 Date of International Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Human Chorionic Gonadotropin (HCG) Market Size by Company
        4.5.1 Top Human Chorionic Gonadotropin (HCG) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Human Chorionic Gonadotropin (HCG) Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Human Chorionic Gonadotropin (HCG) Sales by Players (2020, 2021 & 2022)
5 Global Human Chorionic Gonadotropin (HCG) Market Size by Region
    5.1 Global Human Chorionic Gonadotropin (HCG) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Human Chorionic Gonadotropin (HCG) Market Size in Volume by Region (2017-2028)
        5.2.1 Global Human Chorionic Gonadotropin (HCG) Sales in Volume by Region: 2017-2022
        5.2.2 Global Human Chorionic Gonadotropin (HCG) Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Human Chorionic Gonadotropin (HCG) Market Size in Value by Region (2017-2028)
        5.3.1 Global Human Chorionic Gonadotropin (HCG) Sales in Value by Region: 2017-2022
        5.3.2 Global Human Chorionic Gonadotropin (HCG) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Human Chorionic Gonadotropin (HCG) Market Size YoY Growth 2017-2028
        6.1.2 North America Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Human Chorionic Gonadotropin (HCG) Market Size YoY Growth 2017-2028
        6.3.2 Europe Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Human Chorionic Gonadotropin (HCG) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 EMD Serono, Inc
        7.1.1 EMD Serono, Inc Corporation Information
        7.1.2 EMD Serono, Inc Description and Business Overview
        7.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Products Offered
        7.1.5 EMD Serono, Inc Recent Development
    7.2 Ferring B.V
        7.2.1 Ferring B.V Corporation Information
        7.2.2 Ferring B.V Description and Business Overview
        7.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Products Offered
        7.2.5 Ferring B.V Recent Development
    7.3 Merck & Co., Inc
        7.3.1 Merck & Co., Inc Corporation Information
        7.3.2 Merck & Co., Inc Description and Business Overview
        7.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Products Offered
        7.3.5 Merck & Co., Inc Recent Development
    7.4 Bristol Myers Squibb Company
        7.4.1 Bristol Myers Squibb Company Corporation Information
        7.4.2 Bristol Myers Squibb Company Description and Business Overview
        7.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Products Offered
        7.4.5 Bristol Myers Squibb Company Recent Development
    7.5 Fresenius Kabi AG, LLC
        7.5.1 Fresenius Kabi AG, LLC Corporation Information
        7.5.2 Fresenius Kabi AG, LLC Description and Business Overview
        7.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Products Offered
        7.5.5 Fresenius Kabi AG, LLC Recent Development
    7.6 Scrippslabs
        7.6.1 Scrippslabs Corporation Information
        7.6.2 Scrippslabs Description and Business Overview
        7.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Scrippslabs Human Chorionic Gonadotropin (HCG) Products Offered
        7.6.5 Scrippslabs Recent Development
    7.7 Leebio
        7.7.1 Leebio Corporation Information
        7.7.2 Leebio Description and Business Overview
        7.7.3 Leebio Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Leebio Human Chorionic Gonadotropin (HCG) Products Offered
        7.7.5 Leebio Recent Development
    7.8 Kamiya Biomedical Company
        7.8.1 Kamiya Biomedical Company Corporation Information
        7.8.2 Kamiya Biomedical Company Description and Business Overview
        7.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Products Offered
        7.8.5 Kamiya Biomedical Company Recent Development
    7.9 Sanzyme
        7.9.1 Sanzyme Corporation Information
        7.9.2 Sanzyme Description and Business Overview
        7.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Sanzyme Human Chorionic Gonadotropin (HCG) Products Offered
        7.9.5 Sanzyme Recent Development
    7.10 Cigna
        7.10.1 Cigna Corporation Information
        7.10.2 Cigna Description and Business Overview
        7.10.3 Cigna Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Cigna Human Chorionic Gonadotropin (HCG) Products Offered
        7.10.5 Cigna Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Human Chorionic Gonadotropin (HCG) Industry Chain Analysis
    8.2 Human Chorionic Gonadotropin (HCG) Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Human Chorionic Gonadotropin (HCG) Distributors
    8.3 Human Chorionic Gonadotropin (HCG) Production Mode & Process
    8.4 Human Chorionic Gonadotropin (HCG) Sales and Marketing
        8.4.1 Human Chorionic Gonadotropin (HCG) Sales Channels
        8.4.2 Human Chorionic Gonadotropin (HCG) Distributors
    8.5 Human Chorionic Gonadotropin (HCG) Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Human Chorionic Gonadotropin (HCG) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Human Chorionic Gonadotropin (HCG) Market Trends
    Table 3. Human Chorionic Gonadotropin (HCG) Market Drivers
    Table 4. Human Chorionic Gonadotropin (HCG) Market Challenges
    Table 5. Human Chorionic Gonadotropin (HCG) Market Restraints
    Table 6. Global Human Chorionic Gonadotropin (HCG) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Human Chorionic Gonadotropin (HCG) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Human Chorionic Gonadotropin (HCG) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Human Chorionic Gonadotropin (HCG) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Human Chorionic Gonadotropin (HCG) Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Human Chorionic Gonadotropin (HCG) Sales Share by Manufacturer, 2017-2022
    Table 15. Global Human Chorionic Gonadotropin (HCG) Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Human Chorionic Gonadotropin (HCG) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Human Chorionic Gonadotropin (HCG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2021)
    Table 18. Top Players of Human Chorionic Gonadotropin (HCG) in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
    Table 20. Date of International Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Human Chorionic Gonadotropin (HCG) Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Human Chorionic Gonadotropin (HCG) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Human Chorionic Gonadotropin (HCG) Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Human Chorionic Gonadotropin (HCG) Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Human Chorionic Gonadotropin (HCG) Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Human Chorionic Gonadotropin (HCG) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Human Chorionic Gonadotropin (HCG) Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Human Chorionic Gonadotropin (HCG) Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Human Chorionic Gonadotropin (HCG) Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Human Chorionic Gonadotropin (HCG) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Human Chorionic Gonadotropin (HCG) Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Human Chorionic Gonadotropin (HCG) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Human Chorionic Gonadotropin (HCG) Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Human Chorionic Gonadotropin (HCG) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Human Chorionic Gonadotropin (HCG) Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Human Chorionic Gonadotropin (HCG) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. EMD Serono, Inc Corporation Information
    Table 43. EMD Serono, Inc Description and Business Overview
    Table 44. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product
    Table 46. EMD Serono, Inc Recent Development
    Table 47. Ferring B.V Corporation Information
    Table 48. Ferring B.V Description and Business Overview
    Table 49. Ferring B.V Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Ferring B.V Product
    Table 51. Ferring B.V Recent Development
    Table 52. Merck & Co., Inc Corporation Information
    Table 53. Merck & Co., Inc Description and Business Overview
    Table 54. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Merck & Co., Inc Product
    Table 56. Merck & Co., Inc Recent Development
    Table 57. Bristol Myers Squibb Company Corporation Information
    Table 58. Bristol Myers Squibb Company Description and Business Overview
    Table 59. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Bristol Myers Squibb Company Product
    Table 61. Bristol Myers Squibb Company Recent Development
    Table 62. Fresenius Kabi AG, LLC Corporation Information
    Table 63. Fresenius Kabi AG, LLC Description and Business Overview
    Table 64. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Fresenius Kabi AG, LLC Product
    Table 66. Fresenius Kabi AG, LLC Recent Development
    Table 67. Scrippslabs Corporation Information
    Table 68. Scrippslabs Description and Business Overview
    Table 69. Scrippslabs Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Scrippslabs Product
    Table 71. Scrippslabs Recent Development
    Table 72. Leebio Corporation Information
    Table 73. Leebio Description and Business Overview
    Table 74. Leebio Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Leebio Product
    Table 76. Leebio Recent Development
    Table 77. Kamiya Biomedical Company Corporation Information
    Table 78. Kamiya Biomedical Company Description and Business Overview
    Table 79. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Kamiya Biomedical Company Product
    Table 81. Kamiya Biomedical Company Recent Development
    Table 82. Sanzyme Corporation Information
    Table 83. Sanzyme Description and Business Overview
    Table 84. Sanzyme Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Sanzyme Product
    Table 86. Sanzyme Recent Development
    Table 87. Cigna Corporation Information
    Table 88. Cigna Description and Business Overview
    Table 89. Cigna Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Cigna Product
    Table 91. Cigna Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Human Chorionic Gonadotropin (HCG) Customers List
    Table 95. Human Chorionic Gonadotropin (HCG) Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Chorionic Gonadotropin (HCG) Product Picture
    Figure 2. Global Human Chorionic Gonadotropin (HCG) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Human Chorionic Gonadotropin (HCG) Market Size 2017-2028 (US$ Million)
    Figure 4. Global Human Chorionic Gonadotropin (HCG) Sales 2017-2028 (K Units)
    Figure 5. United States Human Chorionic Gonadotropin (HCG) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Human Chorionic Gonadotropin (HCG) Market Size 2017-2028 (US$ Million)
    Figure 7. United States Human Chorionic Gonadotropin (HCG) Sales 2017-2028 (K Units)
    Figure 8. United States Human Chorionic Gonadotropin (HCG) Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Human Chorionic Gonadotropin (HCG) Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Human Chorionic Gonadotropin (HCG) Report Years Considered
    Figure 11. Product Picture of Natural Source Extraction
    Figure 12. Product Picture of Recombinant DNA Technology
    Figure 13. Global Human Chorionic Gonadotropin (HCG) Market Share by Type in 2022 & 2028
    Figure 14. Global Human Chorionic Gonadotropin (HCG) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Human Chorionic Gonadotropin (HCG) Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Human Chorionic Gonadotropin (HCG) Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Human Chorionic Gonadotropin (HCG) Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Human Chorionic Gonadotropin (HCG) Market Share by Type in 2022 & 2028
    Figure 20. United States Human Chorionic Gonadotropin (HCG) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Human Chorionic Gonadotropin (HCG) Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Human Chorionic Gonadotropin (HCG) Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Human Chorionic Gonadotropin (HCG) Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Female Infertility Treatment
    Figure 26. Product Picture of Oligospermic Treatment
    Figure 27. Product Picture of Cryptorchidism Treatment
    Figure 28. Product Picture of Others
    Figure 29. Global Human Chorionic Gonadotropin (HCG) Market Share by Application in 2022 & 2028
    Figure 30. Global Human Chorionic Gonadotropin (HCG) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Human Chorionic Gonadotropin (HCG) Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Human Chorionic Gonadotropin (HCG) Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Human Chorionic Gonadotropin (HCG) Price by Application (2017-2028) & (USD/Unit)
    Figure 35. United States Human Chorionic Gonadotropin (HCG) Market Share by Application in 2022 & 2028
    Figure 36. United States Human Chorionic Gonadotropin (HCG) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Human Chorionic Gonadotropin (HCG) Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Human Chorionic Gonadotropin (HCG) Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Human Chorionic Gonadotropin (HCG) Price by Application (2017-2028) & (USD/Unit)
    Figure 41. North America Human Chorionic Gonadotropin (HCG) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Human Chorionic Gonadotropin (HCG) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Human Chorionic Gonadotropin (HCG) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Human Chorionic Gonadotropin (HCG) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Human Chorionic Gonadotropin (HCG) Value Chain
    Figure 75. Human Chorionic Gonadotropin (HCG) Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
Frequently Asked Questions
Human Chorionic Gonadotropin (HCG) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Chorionic Gonadotropin (HCG) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Chorionic Gonadotropin (HCG) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports